Maglietta, G., Damato, A., Spada, F., Iachetta, F., Pusceddu, S., Brighi, N., Antonuzzo, L., Buonadonna, A., Gelsomino, F., Masi, G., Ciardiello, G., Gervasi, E., Larocca, M., Pinto, C. (2026). Durvalumab plus platinum-etoposide in extensive-stage extrapulmonary small cell carcinoma (ES-EPSCC): Second safety assessment of the DURVASCC trial (GOIRC-01-2021).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14572